| Literature DB >> 28442394 |
Josef Troger1, Markus Theurl2, Rudolf Kirchmair2, Teresa Pasqua3, Bruno Tota3, Tommaso Angelone3, Maria C Cerra3, Yvonne Nowosielski4, Raphaela Mätzler4, Jasmin Troger4, Jaur R Gayen5, Vance Trudeau6, Angelo Corti7, Karen B Helle8.
Abstract
The granin family comprises altogether 7 different proteins originating from the diffuse neuroendocrine system and elements of the central and peripheral nervous systems. The family is dominated by three uniquely acidic members, namely chromogranin A (CgA), chromogranin B (CgB) and secretogranin II (SgII). Since the late 1980s it has become evident that these proteins are proteolytically processed, intragranularly and/or extracellularly into a range of biologically active peptides; a number of them with regulatory properties of physiological and/or pathophysiological significance. The aim of this comprehensive overview is to provide an up-to-date insight into the distribution and properties of the well established granin-derived peptides and their putative roles in homeostatic regulations. Hence, focus is directed to peptides derived from the three main granins, e.g. to the chromogranin A derived vasostatins, betagranins, pancreastatin and catestatins, the chromogranin B-derived secretolytin and the secretogranin II-derived secretoneurin (SN). In addition, the distribution and properties of the chromogranin A-derived peptides prochromacin, chromofungin, WE14, parastatin, GE-25 and serpinins, the CgB-peptide PE-11 and the SgII-peptides EM66 and manserin will also be commented on. Finally, the opposing effects of the CgA-derived vasostatin-I and catestatin and the SgII-derived peptide SN on the integrity of the vasculature, myocardial contractility, angiogenesis in wound healing, inflammatory conditions and tumors will be discussed.Entities:
Keywords: Angiogenesis; Betagranin; Catestatin; Chromacin; Chromogranin A; Chromogranin B; EM66; GE-25; Homeostatic regulations; Inflammatory conditions; Inhibition of tumor growth; Innate immunity; Manserin; Multifunctional effects; Myocardial protections; Pancreastatin; Parastatin; Prochromacin; Proteolytic processing; Secretogranin II; Secretolytin; Secretoneurin; Serpinins; Vascular integrity; Vasostatin-I; Vasostatin-II; WE-14
Mesh:
Substances:
Year: 2017 PMID: 28442394 DOI: 10.1016/j.pneurobio.2017.04.003
Source DB: PubMed Journal: Prog Neurobiol ISSN: 0301-0082 Impact factor: 11.685